Novel cut‐off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long‐term, follow‐up, retrospective study

OBJECTIVES: Metastatic renal cell carcinoma can occur synchronously or metachronously. We characterized the time from diagnosis to systematic therapy as a categorical variable to analyze its effect on the overall survival and first‐line treatment efficacy of metastatic renal cell carcinoma patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Chuanzhen, Shou, Jianzhong, Shi, Hongzhe, Jiang, Weixing, Kang, Xiangpeng, Xie, Ruiyang, Shang, Bingqing, Bi, Xingang, Zhang, Jin, Zheng, Shan, Zhou, Aiping, Li, Changling, Ma, Jianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles: Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299735/
https://www.ncbi.nlm.nih.gov/pubmed/34847622
http://dx.doi.org/10.1111/iju.14751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299735/
https://www.ncbi.nlm.nih.gov/pubmed/34847622
http://dx.doi.org/10.1111/iju.14751

Ejemplares similares